Top compounds associated with response to AHCY


Feature Type Standardized
Nominal ANOVA
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 4e-06
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.13 6e-05
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA Gemcitabine GDSC1000 pan-cancer AAC 0.13 0.0003
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.12 0.0008
mRNA VX-11e GDSC1000 pan-cancer AAC 0.11 0.001
Download CSV